Crawford Investment Counsel Inc Abb Vie Inc. Transaction History

Crawford Investment Counsel Inc

$5.21 Billion
Q2 2024

A detailed history of Crawford Investment Counsel Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Crawford Investment Counsel Inc holds 964,840 shares of ABBV stock, worth $186 Million. This represents 3.17% of its overall portfolio holdings.

Number of Shares

964,840

Previous 956,032 0.92%

Holding current value

$186 Million

Previous $174 Million 4.94%

% of portfolio

3.17%

Previous 3.26%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $1.36 Million - $1.59 Million	8,808 Added 0.92%	964,840 $165 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $4.94 Million - $5.63 Million	-30,915 Reduced 3.13%	956,032 $174 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $1.97 Million - $2.22 Million	-14,318 Reduced 1.43%	986,947 $153 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $1.03 Million - $1.19 Million	7,693 Added 0.77%	1,001,265 $149 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $1.45 Million - $1.8 Million	10,905 Added 1.11%	993,572 $134 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $4.63 Million - $5.33 Million	-32,030 Reduced 3.16%	982,667 $157 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $2.94 Million - $3.52 Million	-21,227 Reduced 2.05%	1,014,697 $164 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $640,852 - $735,015	-4,775 Reduced 0.46%	1,035,924 $139 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $18.1 Million - $23 Million	-131,360 Reduced 11.21%	1,040,699 $159 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $6.78 Million - $8.42 Million	-51,404 Reduced 4.2%	1,172,059 $190 Million
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $298,977 - $378,293	-2,783 Reduced 0.23%	1,223,463 $166 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $1.89 Million - $2.15 Million	17,797 Added 1.47%	1,226,246 $132 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $9.19 Million - $10.2 Million	87,391 Added 7.8%	1,208,449 $136 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $6.04 Million - $6.65 Million	59,078 Added 5.56%	1,121,058 $121 Million
Q4 2020 Feb 01, 2021	BUY	$80.49 - $108.67 $1.68 Million - $2.27 Million	20,863 Added 2.0%	1,061,980 $114 Million
Q3 2020 Oct 29, 2020	SELL	$85.91 - $100.83 $766,918 - $900,109	-8,927 Reduced 0.85%	1,041,117 $91.2 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $2.35 Million - $3.14 Million	-32,013 Reduced 2.96%	1,050,044 $103 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $4.89 Million - $7.42 Million	75,830 Added 7.54%	1,082,057 $82.4 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $3.69 Million - $4.62 Million	51,209 Added 5.36%	1,006,227 $89.1 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $58.4 Million - $70.2 Million	926,607 Added 3261.44%	955,018 $72.3 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $10,183 - $13,016	155 Added 0.55%	28,411 $2.07 Million
Q1 2019 May 09, 2019	BUY	$77.14 - $90.79 $43,429 - $51,114	563 Added 2.03%	28,256 $2.28 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $241,334 - $297,631	3,100 Added 12.61%	27,693 $2.55 Million
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $13,336 - $14,826	-150 Reduced 0.61%	24,593 $2.33 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $80,263 - $94,969	894 Added 3.75%	24,743 $2.29 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $17,665 - $23,656	192 Added 0.81%	23,849 $2.26 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $105,501 - $115,691	1,178 Added 5.24%	23,657 $2.29 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $1.57 Million - $2.01 Million	22,479	22,479 $2 Million

Others Institutions Holding ABBV

# of Institutions

3,693

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Investment Counsel Inc with notifications on news.

Account

Crawford Investment Counsel Inc Abb Vie Inc. Transaction History